Chronic Obstructive Pulmonary Disease COPD
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - a clinical diagnosis of COPD according to the GOLD criteria - no exacerbation in the month prior to enrolment - >=3 exacerbations or one hospitalization for respiratory problmens in the two years preceeding study entry - (ex)smoker - age>40 years - post-bronchodilator FEV1 25-80% of predicted - able to understand and read Dutch - internet access at home
Exclusion criteria
Exclusion criteria: - serious other disease with a low survival rate -other diseases influencing bronchial symptoms and/or lung function (e.g. cardiac insuficiency, sarcoidosis) - severe psychiatric illness - uncontrolled diabetes mellitus during a COPD exacerbation in the past or a hospitalization for diabetes mellitus in the two year preceding the study - need for regular oxygen therapy (>16 h per day or pO2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The CoCo application will be evaluated among patients in terms of use of the application (registered by system), satisfaction with the application (UTAUT), satisfaction with received care (CSQ), and quality of care (RATER). | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome measures to evaluate the clinical effects are: exacerbations (number, duration), amount of activity (accelerometer, BPAQ), exercise tolerance (6MWT), fatigue (MFI-20), health status and symptoms (CCQ), and quality of life (EQ-5D). | — |
Countries
Netherlands